Cargando…
Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer
Expression of the androgen receptor splice variant 7 (ARV7) in circulating tumor cells (CTCs) has been associated with resistance towards novel androgen receptor (AR)-targeting therapies. While a multitude of ARV7 detection approaches have been developed, the simultaneous enumeration of CTCs and ass...
Autores principales: | Hille, Claudia, Gorges, Tobias M., Riethdorf, Sabine, Mazel, Martine, Steuber, Thomas, Von Amsberg, Gunhild, König, Frank, Peine, Sven, Alix-Panabières, Catherine, Pantel, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770695/ https://www.ncbi.nlm.nih.gov/pubmed/31514447 http://dx.doi.org/10.3390/cells8091067 |
Ejemplares similares
-
Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019) -
EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
por: Vila, Ana, et al.
Publicado: (2016) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of
epithelial EpCAM and mesenchymal N-cadherin
por: Po, Joseph W, et al.
Publicado: (2018)